Theranostics · 2020 · 41 citations · 52 references
MedicineCraniofacial BiologyDevelopmental BiologyBone MetabolismCraniofacial DevelopmentCraniofacial GeneticsBone DevelopmentBone DysplasiasBone FormationOsteogenesisSkeletal DevelopmentSkeletal DysplasiasCraniofacial AbnormalitiesFgfr3-related DisordersFibroblast Growth Factor Receptor 3 (Fgfr3) DisordersLoss-of-function MutationsLoss-of-function Receptor MutationsSkeletal Dysplasia GeneticsSkeletal Dysplasia MutationsSyndromic Hearing Loss
in skeleton development. Our findings provide evidence that modulation of Wnt/β-catenin activity could be a potential therapy for CATSHL syndrome and related skeleton diseases.
52
Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling
Shih-Min A. Huang, Yuji Mishina, Shanming Liu et al. · Nature · 2009 · 2.1K citations
U. Klinge, Joon-Keun Park, B. Klosterhalfen · Pathobiology · 2013 · 1.8K citations · Full text
Fibroblast Growth Factor Receptor 3 Is a Negative Regulator of Bone Growth
Anthony Wynshaw‐Boris, Fen Zhou, Ann Kuo et al. · Cell · 1996 · 1.1K citations · Full text